期刊文献+

急诊室胸痛患者血清心肌钙蛋白Ⅰ检测结果的临床分析 被引量:4

The cTNI value and its Applicability for Chest Pain Patients in Emergency Room
下载PDF
导出
摘要 目的评价急诊胸痛患者血清心肌钙蛋白Ⅰ(cTNI)水平并探讨其与急性心肌梗死的诊断关系。方法对来我院急诊室就诊的胸痛患者的cTNI进行检测并按其轻重程度进行分组分析临床资料,评价急诊患者血清cTNI水平与急性心肌梗死诊断及其伴随疾病的关系。结果胸痛患者297例人选分析,其中血清cTNI值轻度增高组(0.04~0.1 ng/d1)52例、中度增高组(0.1~1 ng/dl)72例及明显增高绀(1~10.0 ng/dl)67例,极高组(>10 ng/dl)10例,以及正常值对照组(<0.04 ng/dl )96例。通过对急诊胸痛患者血清cTNI,肌酸激酶(CK),肌酸激酶同工酶(CKMB),谷草转氨酶(GOT),乳酸脱氢酶浓度(LDH)与急性心肌梗死的ROC曲线分析,对诊断急性心肌梗死的敏感性和特异性,血清cTNI大于总CK和AST,且高于CKMB和LDH,当cTNI为0.107 ng/dl时,其灵敏度和特异度最高,分别为80.5%和73.2%;冠心病组自胸痛发作至测定血清cTNI高点的平均时间为19 h (10.8~26.0 h)。冠心病患者占73.7%,其中急性心肌梗死占53.9%,心绞痛占39.7%。冠心病组与非冠心病比较,冠心病组糖尿病,高血脂,年龄血清cTNI水平均增高明显;非冠心病组风心病cTNI水平明显高于冠心病组。高血压,颈椎病,肾功能不伞,脑梗塞冠心病组与非冠心病比较无差异。结论冠心病是我院急诊室胸痛的主要构成,占73.7%,其中急性心肌梗死占53.9%。血清cTNI测定对急性心肌梗死诊断的敏感性和特异性高于心肌酶学测定,以血清cTNI浓度0.107 ng/dl时,其敏感性和特异性最高。 Objective To evaluate the cTNI value of chest pain patients and its sensitivity and specificity for acute myocardial infarction diagnoses in emergency room, Methods To analysis the clinical data of chest pain patients in our emergency room,that had been test the cTNI,myocardial enzymes( CK, CKMB, LDH, GOT) , qualified history recording, as well as definitely diagnoses, and then analyzed the relation between cTNI value and acute myocardial infarction (AMI), and company diseases, such as hypertension, dyslipidemia ,diabetes mellitus ,renal function failure , rheumatic heart disease (RHD), and stroke, Results There were 297 patients were enrolled, that 52 pts in group 1 ( cTNI 0, 04 - 0.1 ng/dl), 72 pts in group 2 (0, 1 -1 ng/dl), 67 pts in group3 (1 -10.0 ng/dl), 10 pts in group 4 ( 〉 10 ng/dl), as well as the 96 pts with normal range cTNI( 〈 0.04 ng/dl )in group 5. According to its ROC curve,both sensitivity and specificity of cTNI for AMI diagnoses was the greater than creatine kinase, creatine kinase MB, lactae dehydrogenase and serum glutamic-oxaloacetic transaminase ( SGOT ) ( aspartate aminotransferase, AST ) , its optimal cut-off point was 0, 107ng/ml, and its sensitivity and specificity was 80, 5% and 73.2% respectively; the duration time from pain setup to the blood sample took was 19 hrs( 10 -28.5 hrs). 73.7% of patients were coronary heart diseases( CHD), and 53.9% were acute myocardial infarction among CHD ,angina pectoris were 39.7%. Comparisons between CHD and no CHD group, DM, dyslipidemia, age were higher significantly in CHD group than no CHD, and otherwise RHD were higher significantly in no CHD group. Neither of hypertension, diabetes mellitus, dyslipidemia, cervical spondylosis,renal function failure and celebrates vascular diseases had signficandy difference between groups. Conclusion The coronary heart disease were the main part of chest pain patients in emergence room, and its percent were 73.7 and among it 53.9% were acute myocardial infarction. The sensitivity and specificity of cTNI test for AMI diagnoses is the highest than other cardiac enzymes , and its sensitivity and specificity was 80.5% and 73.2% as its cut-off point was 0. 107 ng/dl.
出处 《中国分子心脏病学杂志》 CAS 2007年第6期347-350,共4页 Molecular Cardiology of China
关键词 血清肌钙蛋白Ⅰ 急诊胸痛患者 急性心肌梗死 伴随疾病 cTNI ,Chest Pain Pateins in ER, AMI, Complication Diseases
  • 相关文献

参考文献7

  • 1[2]The Joint European Society of Cardiology/American College of Cardiology Committee.Myocardial Infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction.European Heart Journal,2000,21:1502-1513.
  • 2[3]Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA 2002 guideline update for the management of patient with unstable angina and non-ST-segment elevation myocardial infarction-summary article:a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).J Am Coll Cardiol,2002,40(7):1366-1374.
  • 3潘柏申,杨振华,吴健民.冠状动脉疾病和心力衰竭时心脏标志物临床检测应用建议[J].中华检验医学杂志,2006,29(9):774-778. 被引量:73
  • 4齐丽丽,徐国宾,夏铁安.心肌肌钙蛋白Ⅰ在非ST段抬高急性冠状动脉综合征诊断和预后中的临床应用[J].中华检验医学杂志,2007,30(5):515-519. 被引量:11
  • 5[7]Tian Y,Nie J,Tong TK,Cao J,Gao Q,Man J,Shi Q,Liu W.Changes in serum cardiac troponins following a 21-km run in junior male runners.J Sports Med Phys Fitness,2006 Sep;46 (3):481-488.
  • 6[8]Collinson PO,Premachandram S,Hashemi K.Prospective audit of incidence of prognostically important myocardial damage in patients discharged from emergency department.BMJ,2000320:1702-1705.
  • 7[9]Mehta RH,Eagle KA.Missed diagnoses of acute coronary syndromes in the emergency room-continuing challenges.N Engl J Med,2000,342:1207-1210.

二级参考文献54

  • 1齐丽丽,徐国宾,夏铁安.一种灵敏的肌钙蛋白I方法对心肌梗死诊断的价值[J].诊断学理论与实践,2006,5(2):142-146. 被引量:5
  • 2潘柏申,杨振华,吴健民.冠状动脉疾病和心力衰竭时心脏标志物临床检测应用建议[J].中华检验医学杂志,2006,29(9):774-778. 被引量:73
  • 3Pearson TA, Mensah GA, Hong Y, et al. CDC/AHA Workshop on markers of inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice : Overview. Circulation, 2004,110 : e543-544.
  • 4Myers GL,Rifai N,Tracy RP,et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation ,200d, 110 :e545-549.
  • 5Smith SC Jr, Anderson JL, Cannon RO 3rd, et al. CDC/AHA Workshop on Markers of inflammation and Cardiovascular Disease:Application to Clinical And Public Health Practice: report from the clinical practice discussion group. Circulation,2004, 110 : e550-553.
  • 6Fortmann SP, Ford E, Criqui MH, et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public Health Practice: report from the population science discussion group. Circulation,2004, 110 : e554-559.
  • 7Biasucci LM, CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public Health practice: clinical use of inflammatory markers in Patients with cardiovascular diseases : a background paper.Circulation ,2004, 110 :e560-567.
  • 8Wilson PW, CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease:Application to Clinical and Public Health Practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper. Circulation,2004,110:e568-571.
  • 9Roberts WL, CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease. Application to Clinical and Public Health Practice. laboratory tests available to assess inflammation-performance and standardization: a background paper.Circulation, 2004,110 :e572-578.
  • 10Morrow DA, Braunwald E. Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation, 2003,108:250-252.

共引文献80

同被引文献22

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部